Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.72B |
| 2 |
Meta Platforms (Facebook)
META
|
+$660M |
| 3 |
Micron Technology
MU
|
+$605M |
| 4 |
Mastercard
MA
|
+$497M |
| 5 |
Tesla
TSLA
|
+$495M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.33B |
| 2 |
Visa
V
|
+$1.26B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 4 |
Lam Research
LRCX
|
+$699M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$681M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.37% |
| 2 | Technology | 4.49% |
| 3 | Healthcare | 2.99% |
| 4 | Financials | 2.85% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
BNCWW
12801
BNB Standard Corporation Warrant
BNCWW
| $508 | ﹤0.01% |
16,861
+95
| +0.6% | +$4 |
2025 Q3
2 quarters
|
|
|
KIDZW
12802
KIDZ AI Inc Warrants
KIDZW
$140K
| $488 | ﹤0.01% |
29,580
-1,150
| -4% | -$16 |
2025 Q2
3 quarters
|
|
12803
Beneficient Warrant
BENFW
$149K
| $404 | ﹤0.01% |
+32,320
| New | +$362 |
2026 Q1
0 quarters
|
|
|
NEXRW
12804
Nexera Technologies Ltd Warrant
NEXRW
$65.9K
| $398 | ﹤0.01% |
25,198
-2,758
| -10% | -$46 |
2023 Q2
11 quarters
|
|
|
MKDWW
12805
MKDWELL Tech Inc Warrants
MKDWW
| $363 | ﹤0.01% |
34,604
-649
| -2% | -$8 |
2024 Q3
6 quarters
|
|
12806
SHF Holdings Warrants
SHFSW
$143K
| $356 | ﹤0.01% |
11,871
-1,390
| -10% | -$49 |
2024 Q1
8 quarters
|
|
12807
Cingulate Inc Warrants
CINGW
$18.2K
| $348 | ﹤0.01% |
+11,486
| New | +$737 |
2026 Q1
0 quarters
|
|
|
DAICW
12808
CID HoldCo Inc Warrants
DAICW
$154K
| $304 | ﹤0.01% |
14,739
+475
| +3% | +$21 |
2025 Q2
3 quarters
|
|
|
NXPLW
12809
DELISTED
NextPlat Corp Warrants
NXPLW
| $300 | ﹤0.01% |
12,346
+198
| +2% | +$14 |
2025 Q2
3 quarters
|
|
12810
Revelation Biosciences Warrant
REVBW
| $285 | ﹤0.01% |
32,400
+302
| +0.9% | +$3 |
2023 Q1
12 quarters
|
|
|
XOSWW
12811
DELISTED
Xos Inc Warrants
XOSWW
| $50 | ﹤0.01% |
15,119
-100
| -0.7% | – |
2024 Q1
8 quarters
|
|
12812
GraniteShares 2x Long AAPL Daily ETF
AAPB
$17.4M
| – | – |
-17,552
| Closed | -$508K | – |
|
|
12813
PUT
GraniteShares 2x Long AAPL Daily ETF
AAPB
$17.4M
| – | – |
-7,500
| Closed | -$240K | – |
|
12814
CALL
T-Rex 2X Long Apple Daily Target ETF
AAPX
$9.99M
| – | – |
-6,600
| Closed | -$201K | – |
|
12815
CALL
Acumen Pharmaceuticals
ABOS
$148M
| – | – |
-26,800
| Closed | -$56.5K | – |
|
|
12816
Acumen Pharmaceuticals
ABOS
$148M
| – | – |
-345,283
| Closed | -$881K | – |
|
12817
PUT
Arcosa
ACA
$7.19B
| – | – |
-4,000
| Closed | -$425K | – |
|
12818
ABVC BioPharma
ABVC
$27M
| – | – |
-55,543
| Closed | -$118K | – |
|
12819
Acco Brands
ACCO
$397M
| – | – |
-42,674
| Closed | -$161K | – |
|
12820
PUT
Achieve Life Sciences
ACHV
$746M
| – | – |
-17,000
| Closed | -$84.5K | – |
|
12821
American Coastal Insurance
ACIC
$441M
| – | – |
-52,380
| Closed | -$588K | – |
|
12822
Acrivon Therapeutics
ACRV
$85.3M
| – | – |
-1,641,884
| Closed | -$3.96M | – |
|
12823
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.29B
| – | – |
-12,403
| Closed | -$1.47M | – |
|
|
ADAG
12824
Adagene
ADAG
$191M
| – | – |
-48,385
| Closed | -$91.4K | – |
|
12825
CALL
ADC Therapeutics
ADCT
$144M
| – | – |
-12,100
| Closed | -$42.7K | – |
|
Similar funds
Citadel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Citadel Advisors held 14,860 positions worth $618B, down 7.1% from $666B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citadel Advisors's Q1 2026 filing shows 2,347 new, 5,138 increased, 5,286 reduced and 2,003 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M. The largest sale was Amazon, an estimated $1.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 80% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q1 2026 buy was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.72B increase.
- Citadel Advisors's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.33B.
- Citadel Advisors fully exited CyberArk in Q1 2026, selling an estimated $305M.
- Citadel Advisors's ten largest holdings make up 22% of its $618B portfolio in Q1 2026.
- Citadel Advisors opened 2,347 new positions and closed 2,003 in Q1 2026.
- Citadel Advisors's portfolio value fell 7.1% quarter-over-quarter to $618B.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.